世界の敗血症診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Sepsis Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5190 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、敗血症診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（臨床検査、ポイントオブケア検査）、用途別市場規模（病院、病理学及び参照研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・敗血症診断の市場動向 ・企業の競争状況、市場シェア ・敗血症診断の種類別市場規模（臨床検査、ポイントオブケア検査） ・敗血症診断の用途別市場規模（病院、病理学及び参照研究所） ・敗血症診断の北米市場規模2016-2027（アメリカ、カナダ） ・敗血症診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・敗血症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・敗血症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・敗血症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bruker (US)、CytoSorbents (US)、EKF (US)、T2 Biosystems (US)、Luminex (US)、Thermo Fisher Scientific (US)、bioMerieux (France)、Danaher (US)、Becton, Dickinson and Company (US)、Roche (Switzerland)、Abbott (US)） ・結論

Market Analysis and Insights: Global Sepsis Diagnostic Market
The global Sepsis Diagnostic market size is projected to reach US$ 502.7 million by 2026, from US$ 352.1 million in 2019, at a CAGR of 5.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sepsis Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sepsis Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sepsis Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sepsis Diagnostic market.

Global Sepsis Diagnostic Scope and Market Size
Sepsis Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sepsis Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Laboratory Tests
Point-of-care Tests

Segment by Application
Hospitals
Pathology & Reference Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bruker (US)
CytoSorbents (US)
EKF (US)
T2 Biosystems (US)
Luminex (US)
Thermo Fisher Scientific (US)
bioMerieux (France)
Danaher (US)
Becton, Dickinson and Company (US)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laboratory Tests
1.2.3 Point-of-care Tests
1.3 Market by Application
1.3.1 Global Sepsis Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2016-2027)
2.2 Sepsis Diagnostic Growth Trends by Regions
2.2.1 Sepsis Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sepsis Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Sepsis Diagnostic Industry Dynamic
2.3.1 Sepsis Diagnostic Market Trends
2.3.2 Sepsis Diagnostic Market Drivers
2.3.3 Sepsis Diagnostic Market Challenges
2.3.4 Sepsis Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostic Players by Revenue
3.1.1 Global Top Sepsis Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostic Revenue
3.4 Global Sepsis Diagnostic Market Concentration Ratio
3.4.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2020
3.5 Sepsis Diagnostic Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostic Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sepsis Diagnostic Breakdown Data by Type
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2022-2027)

5 Sepsis Diagnostic Breakdown Data by Application
5.1 Global Sepsis Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sepsis Diagnostic Market Size (2016-2027)
6.2 North America Sepsis Diagnostic Market Size by Type
6.2.1 North America Sepsis Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Sepsis Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Sepsis Diagnostic Market Size by Type (2016-2027)
6.3 North America Sepsis Diagnostic Market Size by Application
6.3.1 North America Sepsis Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Sepsis Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Sepsis Diagnostic Market Size by Application (2016-2027)
6.4 North America Sepsis Diagnostic Market Size by Country
6.4.1 North America Sepsis Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Sepsis Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2016-2027)
7.2 Europe Sepsis Diagnostic Market Size by Type
7.2.1 Europe Sepsis Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Sepsis Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Sepsis Diagnostic Market Size by Type (2016-2027)
7.3 Europe Sepsis Diagnostic Market Size by Application
7.3.1 Europe Sepsis Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Sepsis Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Sepsis Diagnostic Market Size by Application (2016-2027)
7.4 Europe Sepsis Diagnostic Market Size by Country
7.4.1 Europe Sepsis Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Sepsis Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Sepsis Diagnostic Market Size by Type
8.2.1 Asia-Pacific Sepsis Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sepsis Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sepsis Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Sepsis Diagnostic Market Size by Application
8.3.1 Asia-Pacific Sepsis Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sepsis Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sepsis Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Sepsis Diagnostic Market Size by Region
8.4.1 Asia-Pacific Sepsis Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sepsis Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sepsis Diagnostic Market Size (2016-2027)
9.2 Latin America Sepsis Diagnostic Market Size by Type
9.2.1 Latin America Sepsis Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Sepsis Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Sepsis Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Sepsis Diagnostic Market Size by Application
9.3.1 Latin America Sepsis Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Sepsis Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Sepsis Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Sepsis Diagnostic Market Size by Country
9.4.1 Latin America Sepsis Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Sepsis Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Sepsis Diagnostic Market Size by Type
10.2.1 Middle East & Africa Sepsis Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sepsis Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sepsis Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Sepsis Diagnostic Market Size by Application
10.3.1 Middle East & Africa Sepsis Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sepsis Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sepsis Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Sepsis Diagnostic Market Size by Country
10.4.1 Middle East & Africa Sepsis Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sepsis Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bruker (US)
11.1.1 Bruker (US) Company Details
11.1.2 Bruker (US) Business Overview
11.1.3 Bruker (US) Sepsis Diagnostic Introduction
11.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.1.5 Bruker (US) Recent Development
11.2 CytoSorbents (US)
11.2.1 CytoSorbents (US) Company Details
11.2.2 CytoSorbents (US) Business Overview
11.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
11.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.2.5 CytoSorbents (US) Recent Development
11.3 EKF (US)
11.3.1 EKF (US) Company Details
11.3.2 EKF (US) Business Overview
11.3.3 EKF (US) Sepsis Diagnostic Introduction
11.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.3.5 EKF (US) Recent Development
11.4 T2 Biosystems (US)
11.4.1 T2 Biosystems (US) Company Details
11.4.2 T2 Biosystems (US) Business Overview
11.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
11.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.4.5 T2 Biosystems (US) Recent Development
11.5 Luminex (US)
11.5.1 Luminex (US) Company Details
11.5.2 Luminex (US) Business Overview
11.5.3 Luminex (US) Sepsis Diagnostic Introduction
11.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.5.5 Luminex (US) Recent Development
11.6 Thermo Fisher Scientific (US)
11.6.1 Thermo Fisher Scientific (US) Company Details
11.6.2 Thermo Fisher Scientific (US) Business Overview
11.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
11.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.6.5 Thermo Fisher Scientific (US) Recent Development
11.7 bioMerieux (France)
11.7.1 bioMerieux (France) Company Details
11.7.2 bioMerieux (France) Business Overview
11.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
11.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2016-2021)
11.7.5 bioMerieux (France) Recent Development
11.8 Danaher (US)
11.8.1 Danaher (US) Company Details
11.8.2 Danaher (US) Business Overview
11.8.3 Danaher (US) Sepsis Diagnostic Introduction
11.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.8.5 Danaher (US) Recent Development
11.9 Becton, Dickinson and Company (US)
11.9.1 Becton, Dickinson and Company (US) Company Details
11.9.2 Becton, Dickinson and Company (US) Business Overview
11.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
11.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.9.5 Becton, Dickinson and Company (US) Recent Development
11.10 Roche (Switzerland)
11.10.1 Roche (Switzerland) Company Details
11.10.2 Roche (Switzerland) Business Overview
11.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
11.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2016-2021)
11.10.5 Roche (Switzerland) Recent Development
11.11 Abbott (US)
11.11.1 Abbott (US) Company Details
11.11.2 Abbott (US) Business Overview
11.11.3 Abbott (US) Sepsis Diagnostic Introduction
11.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2016-2021)
11.11.5 Abbott (US) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Point-of-care Tests
Table 4. Global Sepsis Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Sepsis Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sepsis Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Sepsis Diagnostic Market Share by Regions (2016-2021)
Table 8. Global Sepsis Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Sepsis Diagnostic Market Share by Regions (2022-2027)
Table 10. Sepsis Diagnostic Market Trends
Table 11. Sepsis Diagnostic Market Drivers
Table 12. Sepsis Diagnostic Market Challenges
Table 13. Sepsis Diagnostic Market Restraints
Table 14. Global Sepsis Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Sepsis Diagnostic Market Share by Players (2016-2021)
Table 16. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Diagnostic as of 2020)
Table 17. Ranking of Global Top Sepsis Diagnostic Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sepsis Diagnostic Product Solution and Service
Table 21. Date of Enter into Sepsis Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sepsis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Sepsis Diagnostic Revenue Market Share by Type (2016-2021)
Table 25. Global Sepsis Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Sepsis Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Sepsis Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Sepsis Diagnostic Revenue Market Share by Application (2016-2021)
Table 29. Global Sepsis Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Sepsis Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Sepsis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Sepsis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Sepsis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Sepsis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Sepsis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Sepsis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Sepsis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Sepsis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Sepsis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Sepsis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Sepsis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Sepsis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Sepsis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Sepsis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sepsis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sepsis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sepsis Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Sepsis Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Sepsis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Sepsis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Sepsis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Sepsis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Sepsis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Sepsis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Sepsis Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Sepsis Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sepsis Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sepsis Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sepsis Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Sepsis Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bruker (US) Company Details
Table 62. Bruker (US) Business Overview
Table 63. Bruker (US) Sepsis Diagnostic Product
Table 64. Bruker (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 65. Bruker (US) Recent Development
Table 66. CytoSorbents (US) Company Details
Table 67. CytoSorbents (US) Business Overview
Table 68. CytoSorbents (US) Sepsis Diagnostic Product
Table 69. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 70. CytoSorbents (US) Recent Development
Table 71. EKF (US) Company Details
Table 72. EKF (US) Business Overview
Table 73. EKF (US) Sepsis Diagnostic Product
Table 74. EKF (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 75. EKF (US) Recent Development
Table 76. T2 Biosystems (US) Company Details
Table 77. T2 Biosystems (US) Business Overview
Table 78. T2 Biosystems (US) Sepsis Diagnostic Product
Table 79. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 80. T2 Biosystems (US) Recent Development
Table 81. Luminex (US) Company Details
Table 82. Luminex (US) Business Overview
Table 83. Luminex (US) Sepsis Diagnostic Product
Table 84. Luminex (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 85. Luminex (US) Recent Development
Table 86. Thermo Fisher Scientific (US) Company Details
Table 87. Thermo Fisher Scientific (US) Business Overview
Table 88. Thermo Fisher Scientific (US) Sepsis Diagnostic Product
Table 89. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 90. Thermo Fisher Scientific (US) Recent Development
Table 91. bioMerieux (France) Company Details
Table 92. bioMerieux (France) Business Overview
Table 93. bioMerieux (France) Sepsis Diagnostic Product
Table 94. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 95. bioMerieux (France) Recent Development
Table 96. Danaher (US) Company Details
Table 97. Danaher (US) Business Overview
Table 98. Danaher (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 99. Danaher (US) Recent Development
Table 100. Becton, Dickinson and Company (US) Company Details
Table 101. Becton, Dickinson and Company (US) Business Overview
Table 102. Becton, Dickinson and Company (US) Sepsis Diagnostic Product
Table 103. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 104. Becton, Dickinson and Company (US) Recent Development
Table 105. Roche (Switzerland) Company Details
Table 106. Roche (Switzerland) Business Overview
Table 107. Roche (Switzerland) Sepsis Diagnostic Product
Table 108. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 109. Roche (Switzerland) Recent Development
Table 110. Abbott (US) Company Details
Table 111. Abbott (US) Business Overview
Table 112. Abbott (US) Sepsis Diagnostic Product
Table 113. Abbott (US) Revenue in Sepsis Diagnostic Business (2016-2021) & (US$ Million)
Table 114. Abbott (US) Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sepsis Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Laboratory Tests Features
Figure 3. Point-of-care Tests Features
Figure 4. Global Sepsis Diagnostic Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Pathology & Reference Laboratories Case Studies
Figure 7. Sepsis Diagnostic Report Years Considered
Figure 8. Global Sepsis Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Sepsis Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Sepsis Diagnostic Market Share by Regions: 2020 VS 2027
Figure 11. Global Sepsis Diagnostic Market Share by Regions (2022-2027)
Figure 12. Global Sepsis Diagnostic Market Share by Players in 2020
Figure 13. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Diagnostic as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2020
Figure 15. Global Sepsis Diagnostic Revenue Market Share by Type (2016-2021)
Figure 16. Global Sepsis Diagnostic Revenue Market Share by Type (2022-2027)
Figure 17. North America Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Sepsis Diagnostic Market Share by Type (2016-2027)
Figure 19. North America Sepsis Diagnostic Market Share by Application (2016-2027)
Figure 20. North America Sepsis Diagnostic Market Share by Country (2016-2027)
Figure 21. United States Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sepsis Diagnostic Market Share by Type (2016-2027)
Figure 25. Europe Sepsis Diagnostic Market Share by Application (2016-2027)
Figure 26. Europe Sepsis Diagnostic Market Share by Country (2016-2027)
Figure 27. Germany Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sepsis Diagnostic Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Sepsis Diagnostic Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Sepsis Diagnostic Market Share by Region (2016-2027)
Figure 37. China Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sepsis Diagnostic Market Share by Type (2016-2027)
Figure 45. Latin America Sepsis Diagnostic Market Share by Application (2016-2027)
Figure 46. Latin America Sepsis Diagnostic Market Share by Country (2016-2027)
Figure 47. Mexico Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sepsis Diagnostic Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Sepsis Diagnostic Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Sepsis Diagnostic Market Share by Country (2016-2027)
Figure 53. Turkey Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Sepsis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Bruker (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 57. CytoSorbents (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 58. EKF (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 59. T2 Biosystems (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 60. Luminex (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 61. Thermo Fisher Scientific (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 62. bioMerieux (France) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 63. Danaher (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 64. Becton, Dickinson and Company (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 65. Roche (Switzerland) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 66. Abbott (US) Revenue Growth Rate in Sepsis Diagnostic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---